Lipae, Lucky L.

HRN: 28-73-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/28/2026
06/03/2026
IV
62mg
Q24
PCAPC
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines